RUA Life Sciences plc (RUA) ORD GBP0.05

Sell:12.00pBuy:13.00p0.25p (2.04%)

Prices delayed by at least 15 minutes
Sell:12.00p
Buy:13.00p
Change:0.25p (2.04%)
Prices delayed by at least 15 minutes
Sell:12.00p
Buy:13.00p
Change:0.25p (2.04%)
Prices delayed by at least 15 minutes

Company Information

About this company

RUA Life Sciences plc is a United Kingdom-based holding company of a group of medical device businesses focused on the exploitation of long-term implantable biostable polymer (Elast-Eon). Elast-Eon's biostability is comparable to silicone while exhibiting excellent mechanical, blood contacting and flex-fatigue properties. The Company has four business units: RUA Contract Manufacture, RUA Biomaterials, RUA Vascular and RUA Structural Heart. RUA Contract Manufacture is an end-to-end contract developer and manufacturer of medical devices and implantable fabric specialist. It provides sub-contract manufacturing, assembly, packing and services to the medical device sector from its Class 7 and 8 cleanroom suites. RUA Biomaterials is a licensor of Elast-Eon polymers to the medical device industry. RUA Vascular is engaged in the commercialization of open surgical vascular grafts and patches. RUA Structural Heart is engaged in the development of polymeric leaflet systems for heart valves.

Key people

William Donald Brown
Chief Executive Officer
Lachlan Arthur Smith
Chief Financial Officer, Executive Director, Company Secretary
John Mckenna
Director of Marketing, Executive Director
Geoffrey Berg
Independent Non-Executive Chairman of the Board
Ian Ardill
Non-Executive Independent Director
John L. Ely
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    RUA
  • Location
    United Kingdom
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    GB0033360586
  • Market cap
    £7.76m
  • Employees
    33
  • Shares in issue
    62.06m
  • Exchange
    London Stock Exchange (LON)
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.